Collaborations

Genome-wide line of RNA assays for gene silencing measurement launched

Published in Gene Therapy Weekly, August 19th, 2004

Dharmacon, Inc., a supplier of RNA and RNA interference (RNAi) research products, and Genospectra, Inc., the exclusive supplier of QuantiGene branched DNA (bDNA) gene expression profiling technology, announced an agreement to launch a genome-wide line of assays specifically designed to measure RNA changes directly from cell lysates, fresh tissue, and archived tissue samples.

The new QuantiGene human genome RNA profiling products will, according to the companies, provide accurate and precise measurement of gene-silencing experiments using small interfering RNA (siRNA). When used together, QuantiGene bDNA assays and SMARTpool siRNA products will allow researchers to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2004-08-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry